Clinical Trials Logo

Filter by:
NCT ID: NCT05505370 Completed - Colonic Neoplasms Clinical Trials

Case Series With Saneso 3600 Colonoscope

Start date: April 21, 2022
Phase: N/A
Study type: Interventional

Saneso colonoscope is a novel FDA cleared colonoscope that provides a 360 degree integrated view of the colon. Saneso colonoscope has five cameras and multiple LED lights at the distal head. The objective of the present study is to evaluate clinical success of the Saneso colonoscope in intubation of the terminal ileum and to obtain user feedback with regards to usability characteristics compared to predicate devices.

NCT ID: NCT05505292 Completed - Dry Eye Clinical Trials

Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers

Start date: September 22, 2022
Phase: Phase 4
Study type: Interventional

This is a prospective, single site, randomized, double masked, comparator-controlled study designed to evaluate the efficacy of lifitegrast ophthalmic solution 5% in treating the symptoms of dry eye in soft contact lens wearers as compared to control. We hypothesize that there will be a significant improvement in dry eye symptoms in contact lens wearers using lifitegrast as compared to those being treated with control (lifitegrast vehicle).

NCT ID: NCT05505162 Completed - Clinical trials for Healthy Female Participants

Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.

Start date: August 24, 2022
Phase: Phase 1
Study type: Interventional

A study to assess the Pharmacokinetics (PK) of combined oral ethinyl estradiol (EE) and levonorgestrel (LNG) in healthy female participants of non-child-bearing potential, when administered alone and in combination with multiple oral doses of zibotentan.

NCT ID: NCT05505136 Completed - Cardiac Arrhythmia Clinical Trials

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

MAPS II
Start date: August 30, 2022
Phase:
Study type: Observational

To determine the associations among biometric data and previously reported medication changes in the original MAPS study

NCT ID: NCT05505045 Completed - Clinical trials for Breast Cancer Female

Metacognitive Strategy Training in Cancer-related Cognitive Impairment

Start date: October 11, 2022
Phase: N/A
Study type: Interventional

The first aim of this study is to determine the feasibility of delivering CO-OP remotely to breast cancer survivors, who self-report cancer-related cognitive impairment (CRCI), in preparation for a future R01 trial. The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to attention control, on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI.

NCT ID: NCT05504889 Completed - Pregnancy Related Clinical Trials

Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum

CAMCAP
Start date: June 17, 2022
Phase:
Study type: Observational

This study addresses the second aim of the grant (R01 HD0899455), which is to determine temporal changes in CYP3A4-mediated drug metabolism sequentially across pregnancy and after birth.

NCT ID: NCT05504733 Completed - Clinical trials for Traumatic Hemorrhage

LAVA TQ Doppler Functionality Study

Start date: May 9, 2022
Phase: N/A
Study type: Interventional

This is a single-blinded, randomized clinical trial to determine if the Layperson Audiovisual Assist tourniquet's (LAVA TQ) ability to occlude arterial blood flow is non-inferior to that of the Combat Application Tourniquet (CAT).

NCT ID: NCT05504395 Completed - Clinical trials for Prader-Willi Syndrome

A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome

Start date: November 14, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this Phase 1 study is to evaluate the pharmacokinetics (PK) and safety of a single dose of CSTI-500 10 mg in subjects with Prader-Willi syndrome (PWS) between 13 and 50 years of age with a genetically confirmed diagnosis of PWS.

NCT ID: NCT05503784 Completed - Sweat Clinical Trials

Study to Evaluate the Efficacy of Bite's Natural Deodorant

Start date: November 26, 2021
Phase: N/A
Study type: Interventional

This is an open-label observational single-arm clinical trial to study the efficacy of a commercial deodorant and its effect on odor, clothing (stains), and quality of life. It is hypothesized that the deodorant marketed as Bite deodorant will mask bodily odor in participants, will not stain clothes, and improve the quality of life in trial participants.

NCT ID: NCT05503511 Completed - Alzheimer Disease Clinical Trials

Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects

Start date: October 20, 2022
Phase: Phase 1
Study type: Interventional

Study NPT 2042 CL 101 is a first in human (FIH) study to evaluate the safety and pharmacokinetics (PK) of single and repeated ascending doses of NPT 2042 in healthy adult male and female subjects.